We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

58 hedge funds and large institutions have $13M invested in Korro Bio in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.41% less ownership

Funds ownership: 0.91% → 0.5% (-0.41%)

32% less funds holding

Funds holding: 85 → 58 (-27)

52% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 21

66% less capital invested

Capital invested by funds: $38.1M → $13M (-$25.1M)

71% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 34

Holders
58
Holders Change
-27
Holders Change %
-31.76%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
21
Closed
34
Calls
$555K
Puts
–
Net Calls
+$555K
Net Calls Change
+$417K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$714K
2
Renaissance Technologies
Renaissance Technologies
New York
+$450K
3
Millennium Management
Millennium Management
New York
+$276K
4
E
Ergoteles
New York
+$211K
5
Citadel Advisors
Citadel Advisors
Florida
+$166K

Top Sellers

1
N
Nuveen
North Carolina
-$4.96M
2
WA
Wasatch Advisors
Utah
-$2.22M
3
BlackRock
BlackRock
New York
-$2.11M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.91M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.66M +$714K +10,565 +42%
BlackRock
2
BlackRock
New York
$2.61M -$2.11M -31,290 -47%
Federated Hermes
3
Federated Hermes
Pennsylvania
$2.33M -$1.91M -28,327 -48%
WA
4
Wasatch Advisors
Utah
$1M -$2.22M -32,792 -71%
Renaissance Technologies
5
Renaissance Technologies
New York
$927K +$450K +6,653 +116%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$449K -$392K -5,804 -49%
Millennium Management
7
Millennium Management
New York
$436K +$276K +4,085 +236%
GCP
8
GSA Capital Partners
United Kingdom
$314K -$125K -1,845 -31%
E
9
Ergoteles
New York
$234K +$211K +3,126 New
State Street
10
State Street
Massachusetts
$186K -$616K -9,110 -79%
Citadel Advisors
11
Citadel Advisors
Florida
$183K +$166K +2,453 New
VOYA Investment Management
12
VOYA Investment Management
Georgia
$157K +$8.18K +121 +6%
AQR Capital Management
13
AQR Capital Management
Connecticut
$151K +$96.8K +1,432 +245%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$134K +$94.9K +1,404 +369%
BCM
15
Bridgeway Capital Management
Texas
$133K – – –
Goldman Sachs
16
Goldman Sachs
New York
$114K -$118K -1,749 -53%
WPW
17
Waldron Private Wealth
Pennsylvania
$106K +$95.5K +1,413 New
Morgan Stanley
18
Morgan Stanley
New York
$99K +$18.9K +279 +27%
Northern Trust
19
Northern Trust
Illinois
$91K -$287K -4,247 -78%
NSIM
20
North Star Investment Management
Illinois
$90K – – –
JIP
21
Jaffetilchin Investment Partners
Florida
$71K – – –
NFC
22
Northeast Financial Consultants
Connecticut
$69K – – –
CAM
23
Cresset Asset Management
Illinois
$56K – – –
Prudential Financial
24
Prudential Financial
New Jersey
$36K +$32K +474 New
Qube Research & Technologies (QRT)
25
Qube Research & Technologies (QRT)
United Kingdom
$35K +$31.4K +465 New
1
2 3 4

KRRO Hedge Fund Activity: Q2 2022 in Review

58 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2022, worth a combined $13M — down 66% from $38.1M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of KRRO and 10 opened new positions — a net loss of 24 holders — while 21 trimmed existing stakes and 10 added.

The largest buyer was Vanguard Group, adding an estimated $714K. The largest seller was Nuveen, exiting entirely with an estimated $4.96M sold.

  • 58 institutional investors held Korro Bio (KRRO) as of Q2 2022, down from 85 in Q1 2022.
  • Funds reported $13M of Korro Bio stock for Q2 2022, down 66% quarter-over-quarter.
  • 10 funds opened new Korro Bio positions in Q2 2022 and 34 closed out, a net change of -24 holders.
  • The largest Korro Bio buyer in Q2 2022 was Vanguard Group, an estimated $714K added.
  • The largest Korro Bio seller in Q2 2022 was Nuveen, an estimated $4.96M sold.

Based on aggregated 13F filings for Q2 2022.